Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1

Amin Haghighat Jahromi, Yuan Fu, Kali A. Miller, Lien Nguyen, Long M. Luu, Anne M. Baranger, Steven C. Zimmerman

Research output: Contribution to journalArticle

Abstract

An expanded CUG repeat transcript (CUGexp) is the causative agent of myotonic dystrophy type 1 (DM1) by sequestering muscleblind-like 1 protein (MBNL1), a regulator of alternative splicing. On the basis of a ligand (1) that was previously reported to be active in an in vitro assay, we present the synthesis of a small library containing 10 dimeric ligands (4-13) that differ in length, composition, and attachment point of the linking chain. The oligoamino linkers gave a greater gain in affinity for CUG RNA and were more effective when compared to oligoether linkers. The most potent in vitro ligand (9) was shown to be aqueous-soluble and both cell- and nucleus-permeable, displaying almost complete dispersion of MBNL1 ribonuclear foci in a DM1 cell model. Direct evidence for the bioactivity of 9 was observed in its ability to disperse ribonuclear foci in individual live DM1 model cells using time-lapse confocal fluorescence microscopy.

Original languageEnglish (US)
Pages (from-to)9471-9481
Number of pages11
JournalJournal of Medicinal Chemistry
Volume56
Issue number23
DOIs
StatePublished - Dec 12 2013

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1'. Together they form a unique fingerprint.

  • Cite this